N/A Completed N=45 Diagnostic

A Study of the GRIP Influenza and SARS-CoV-2 POC Assays

COVID · Influenza

Source: ClinicalTrials.gov NCT05674370 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Mar 2024

Primary outcomePrimary: Positive Percent Agreement — 52 percent of nasal swabs

Summary

The purpose of this research is to determine if the use of a new device can accurately detect a virus infection.

Outcome Measures

Outcome	Result	p-value
PRIMARY Positive Percent Agreement	52	—
PRIMARY Negative Percent Agreement	44	—

Eligibility Criteria

Inclusion Criteria

Patients being tested for COVID 19 or Influenza

Exclusion Criteria

Patients < 18 years of age

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05674370). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.